Takeda Pharmaceutical announced the launch of LIOVEL®, a fixed dose combination tablet of NESINA® (alogliptin) and ACTO…
Actos
Long Term Use of Diabetes Drug Actos May Increase Risk of Cancer
The U.S. Food and Drug Administration (FDA) issued a safety announcement informing the public that use of the type 2 dia…
Teva To Market a Generic Version of ACTOS in 2012
Takeda Pharmaceutical Company Limited has granted Teva Pharmaceutical Industries Ltd. a license to market a generic vers…
Actos Ongoing FDA Safety Review: Potential Increased Risk of Bladder Cancer
The FDA notified healthcare professionals and patients that the Agency is reviewing data from an ongoing, ten-year epide…
Actos as Dangerous as Avandia, New Study Shows
The continuing controversy surrounding the cardiovascular risk of GlaxoSmithKline's diabetes drug Avandia has led to sha…
Diabetes Drug Maker Hid Study Data
Avandia Safety Questioned: The New York Times reports that diabetes drug maker SmithKline did not reveal the results of…
Avandia Harms The Heart, Studies Find
Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure …
Takeda and Amylin to Co-develop Obesity Treatments
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commerc…
